Glimepiride; Pioglitazone Hydrochloride is Used for improving glycemic control in patients with type 2 diabetes. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Duetact on Jul 28, 2006. 2 different companies have introduced drugs containing Glimepiride; Pioglitazone Hydrochloride.

Glimepiride; Pioglitazone Hydrochloride Patents

Given below is the list of patents protecting Glimepiride; Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Duetact	US8071130	Solid preparation	Jun 08, 2028	Takeda Pharms Usa
Duetact	US7700128	Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester	Jan 30, 2027	Takeda Pharms Usa
Duetact	US6303640	Pharmaceutical composition	Aug 09, 2016 (Expired)	Takeda Pharms Usa
Duetact	US6150383	Pharmaceutical composition	Jun 19, 2016 (Expired)	Takeda Pharms Usa
Duetact	US6211205	Pharmaceutical composition	Jun 19, 2016 (Expired)	Takeda Pharms Usa
Duetact	US6329404	Pharmaceutical composition	Jun 19, 2016 (Expired)	Takeda Pharms Usa
Duetact	US7538125	Pharmaceutical composition	Jun 19, 2016 (Expired)	Takeda Pharms Usa

Add above patents to watchlist

Glimepiride; Pioglitazone Hydrochloride's Family Patents

Full family tree

Glimepiride; Pioglitazone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Glimepiride; Pioglitazone Hydrochloride.

Given below is the list of companies who have filed for Glimepiride; Pioglitazone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.